I think the big upside is just literally the time that has passed and the progress that hopefully customers and programs have made. 2017 should see some decent production revenue from syringes unless those contracts are not worthy and then some pump sales for trials. all up good times ahead i think - just be nice to get some credibility and have a new era of under promising and actually delivering!
UNS Price at posting:
8.8¢ Sentiment: Buy Disclosure: Held
